Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ruxue Han"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Gonadotropin-releasing hormone agonist (GnRHa) appears to exhibit ovarian protection during chemotherapy for malignant tumors. The purpose of this study was to analyze the benefits of GnRHa in premenopausal women undergoing hematopoietic cel
Externí odkaz:
https://doaj.org/article/793df31be86a4aefa4a5ed6f9ed049fd
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 2702-2712 (2023)
Abstract Background Recent evidence suggested a potential correlation between BMI and the efficacy of immune checkpoint inhibitors in cancer patients. This study aimed to evaluate the prognostic value of the body mass index (BMI) in recurrent/metasta
Externí odkaz:
https://doaj.org/article/d01db6c888524d4990c12f9f778a7b3b
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Chinese medicine (CM) is widely used for treating hyperlipidemias, especially in China. However, the heterogeneity of outcomes measured and reported across trials exacerbates the obstacles of evidence synthesis and effectiveness compariso
Externí odkaz:
https://doaj.org/article/03598c45701a48c9a80505cc7fec5bcf
Autor:
Ruxue, Han1 hrx@njust.edu.cn, Haomin, Zhou1 zhouhm@njust.edu.cn, Jiangtao, Zhong1 zhong_jt@njust.edu.cn, Chengzhi, Zhang1 zhangcz@njust.edu.cn
Publikováno v:
Proceedings of the Association for Information Science & Technology. Oct2022, Vol. 59 Issue 1, p89-99. 11p.
Publikováno v:
Cancer Medicine. 12:2702-2712
Recent evidence suggested a potential correlation between BMI and the efficacy of immune checkpoint inhibitors in cancer patients. This study aimed to evaluate the prognostic value of the body mass index (BMI) in recurrent/metastatic head and neck sq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30bffd4bbe4e845ddd40f6d870a8bf56
https://doi.org/10.1002/cam4.5152
https://doi.org/10.1002/cam4.5152
Serum exomiR content in perimenopausal women with hot flashes-effects of hormone replacement therapy
Objective Hormone replacement therapy (HRT) is the most effective treatment for hot flushes, which is the most common symptom of the climacteric. This study aims to explored whether estrogen can relieve the hot flushes of menopause by regulating the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d3a648bbea1189230848d7127ae1f7a
https://doi.org/10.21203/rs.3.rs-2668612/v1
https://doi.org/10.21203/rs.3.rs-2668612/v1
Objective: The purpose of this study was to analyze the benefits of gonadotropin-releasing hormone agonist (GnRHa) in premenopausal women undergoing hematopoietic cell transplantation(HSCT). Methods: Candidates for myeloablative chemotherapy HSCT req
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9940ef4f3c6cfeec06190ee140dfabb
https://doi.org/10.21203/rs.3.rs-2360036/v1
https://doi.org/10.21203/rs.3.rs-2360036/v1
Publikováno v:
Advances in Integrative Medicine. 6:S140
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ded695ce5404d3dedb0452bf9509f8ec
https://doi.org/10.1016/j.aimed.2019.03.408
https://doi.org/10.1016/j.aimed.2019.03.408